125I-AnnA1 IgG

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Name125I-AnnA1 IgG
Drug Alias NameI125-labelled anti-annexin A1 antibodies (Sidney Kimmel Cancer Center)
ClassificationRadiation-emitting productsBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate
Mechanisms of ActionAnnexin A1 modulators
TargetsAnnexin A1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSidney Kimmel Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSidney Kimmel Cancer Center
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A